Posts in Blog
Building trust: Engaging communities in the future of digital medicines manufacturing

At DM2, we recognize the vital role of public trust in the integration of digital technologies in medicine manufacturing. Through our outreach efforts we engaged a local community, gathering insights and addressing concerns about AI and robotics in healthcare. By fostering open dialogue, we aim to shift perceptions, paving the way for a brighter future in medicine.

Read More
Leading global CDMO Ajinomoto Bio-Pharma Services joins CMAC as new Translation to Industry Collaborator.

Global CDMO Ajinomoto Bio-Pharma Services has become the first organisation to position itself as a Translation to Industry Collaborator within CMAC, a world-leading centre for medicines manufacturing at the University of Strathclyde.

Read More